fanta.bio Sample: CNhs12233
11837 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| Brd4 SRX5782039 | Leukemia stem cell lines Blood | 637 / 14407 (4.4%) | 514 / 144070 (0.4%) | −324.0 | −324.0 | 12.39 |
| Eomes SRX4904815 | Natural killer cells Blood | 3735 / 14407 (25.9%) | 3587 / 144070 (2.5%) | −324.0 | −324.0 | 10.41 |
| Asxl1 SRX3341232 | ES cells Pluripotent stem cell | 2785 / 14407 (19.3%) | 2727 / 144070 (1.9%) | −324.0 | −324.0 | 10.21 |
| Epitope tags SRX13233372 | Testis Gonad | 1270 / 14407 (8.8%) | 1341 / 144070 (0.9%) | −324.0 | −324.0 | 9.47 |
| Kdm6a SRX16085105 | Hematopoietic progenitors Blood | 1006 / 14407 (7.0%) | 1354 / 144070 (0.9%) | −324.0 | −324.0 | 7.43 |
| Epitope tags SRX7884346 | Acute myeloid leukemia Blood | 834 / 14407 (5.8%) | 1125 / 144070 (0.8%) | −324.0 | −324.0 | 7.41 |
| GFP SRX8244566 | Hematopoietic progenitors Blood | 1222 / 14407 (8.5%) | 1652 / 144070 (1.1%) | −324.0 | −324.0 | 7.40 |
| Med1 SRX3729400 | Hematopoietic progenitors Blood | 940 / 14407 (6.5%) | 1335 / 144070 (0.9%) | −324.0 | −324.0 | 7.04 |
| Epitope tags SRX7884347 | Acute myeloid leukemia Blood | 911 / 14407 (6.3%) | 1305 / 144070 (0.9%) | −324.0 | −324.0 | 6.98 |
| Rnf2 SRX7278120 | Hematopoietic progenitors Blood | 883 / 14407 (6.1%) | 1290 / 144070 (0.9%) | −324.0 | −324.0 | 6.84 |
| Epitope tags SRX10239037 | Natural killer cells Blood | 847 / 14407 (5.9%) | 1246 / 144070 (0.9%) | −324.0 | −324.0 | 6.80 |
| Kdm6a SRX16085103 | Hematopoietic progenitors Blood | 994 / 14407 (6.9%) | 1471 / 144070 (1.0%) | −324.0 | −324.0 | 6.76 |
| Med1 SRX3729401 | Hematopoietic progenitors Blood | 920 / 14407 (6.4%) | 1365 / 144070 (0.9%) | −324.0 | −324.0 | 6.74 |
| Ikzf1 SRX8994274 | B cells Blood | 954 / 14407 (6.6%) | 1462 / 144070 (1.0%) | −324.0 | −324.0 | 6.53 |
| Brd4 SRX8934799 | B cells Blood | 1223 / 14407 (8.5%) | 1909 / 144070 (1.3%) | −324.0 | −324.0 | 6.41 |
| Brd4 SRX8934800 | B cells Blood | 948 / 14407 (6.6%) | 1502 / 144070 (1.0%) | −324.0 | −324.0 | 6.31 |
| Brd4 SRX2522377 | Lymphoma cell lines Blood | 1001 / 14407 (6.9%) | 1600 / 144070 (1.1%) | −324.0 | −324.0 | 6.26 |
| Med1 SRX206369 | Pro-B cells Blood | 1398 / 14407 (9.7%) | 2300 / 144070 (1.6%) | −324.0 | −324.0 | 6.08 |
| Ets1 SRX1881673 | B cells Blood | 1408 / 14407 (9.8%) | 2319 / 144070 (1.6%) | −324.0 | −324.0 | 6.07 |
| Rag1 SRX1046534 | Thymocytes Blood | 1438 / 14407 (10.0%) | 2383 / 144070 (1.7%) | −324.0 | −324.0 | 6.03 |
| Brd4 SRX3113705 | CD4+ T cells Blood | 919 / 14407 (6.4%) | 1539 / 144070 (1.1%) | −324.0 | −324.0 | 5.97 |
| Bcl11b SRX12709527 | CD8+ T cells Blood | 1333 / 14407 (9.3%) | 2248 / 144070 (1.6%) | −324.0 | −324.0 | 5.93 |
| Brd4 SRX3729384 | Hematopoietic progenitors Blood | 1340 / 14407 (9.3%) | 2276 / 144070 (1.6%) | −324.0 | −324.0 | 5.89 |
| Runx3 SRX338019 | Natural killer cells Blood | 1136 / 14407 (7.9%) | 1930 / 144070 (1.3%) | −324.0 | −324.0 | 5.89 |
| Ets1 SRX1881674 | B cells Blood | 1346 / 14407 (9.3%) | 2290 / 144070 (1.6%) | −324.0 | −324.0 | 5.88 |
| Spi1 SRX2499698 | Scid.adh.2c2 Blood | 1108 / 14407 (7.7%) | 1922 / 144070 (1.3%) | −324.0 | −324.0 | 5.76 |
| Brd4 SRX1465788 | B cells Blood | 1541 / 14407 (10.7%) | 2675 / 144070 (1.9%) | −324.0 | −324.0 | 5.76 |
| Runx1 SRX7821112 | Hematopoietic progenitors Blood | 1166 / 14407 (8.1%) | 2027 / 144070 (1.4%) | −324.0 | −324.0 | 5.75 |
| Runx1 SRX1939447 | Lymphoid-primed multipotent progenitors Blood | 1162 / 14407 (8.1%) | 2028 / 144070 (1.4%) | −324.0 | −324.0 | 5.73 |
| Ikzf1 SRX149204 | B3 Blood | 999 / 14407 (6.9%) | 1760 / 144070 (1.2%) | −324.0 | −324.0 | 5.68 |
| Ets1 SRX2162542 | Pre-B cells Blood | 1311 / 14407 (9.1%) | 2319 / 144070 (1.6%) | −324.0 | −324.0 | 5.65 |
| Epitope tags SRX11667686 | Pre-B cells Blood | 1129 / 14407 (7.8%) | 1998 / 144070 (1.4%) | −324.0 | −324.0 | 5.65 |
| Brd4 SRX10701688 | Spleen Spleen | 1092 / 14407 (7.6%) | 1938 / 144070 (1.3%) | −324.0 | −324.0 | 5.63 |
| Ikzf1 SRX149203 | B3 Blood | 1133 / 14407 (7.9%) | 2035 / 144070 (1.4%) | −324.0 | −324.0 | 5.57 |
| Nipbl SRX13845190 | Scid.adh.2c2 Blood | 1126 / 14407 (7.8%) | 2044 / 144070 (1.4%) | −324.0 | −324.0 | 5.51 |
| Rag2 SRX018809 | Thymocytes Blood | 1295 / 14407 (9.0%) | 2368 / 144070 (1.6%) | −324.0 | −324.0 | 5.47 |
| Med12 SRX5086065 | Th2 Cells Blood | 1099 / 14407 (7.6%) | 2020 / 144070 (1.4%) | −324.0 | −324.0 | 5.44 |
| Stat5a SRX2975359 | Natural killer cells Blood | 1554 / 14407 (10.8%) | 2875 / 144070 (2.0%) | −324.0 | −324.0 | 5.41 |
| Spi1 SRX2499719 | Scid.adh.2c2 Blood | 1230 / 14407 (8.5%) | 2281 / 144070 (1.6%) | −324.0 | −324.0 | 5.39 |
| Nipbl SRX5730170 | B cells Blood | 1290 / 14407 (9.0%) | 2400 / 144070 (1.7%) | −324.0 | −324.0 | 5.38 |
| Med12 SRX5086064 | Th2 Cells Blood | 1035 / 14407 (7.2%) | 1931 / 144070 (1.3%) | −324.0 | −324.0 | 5.36 |
| Smarca4 SRX7807054 | Embryonic liver Embryo | 1751 / 14407 (12.2%) | 3285 / 144070 (2.3%) | −324.0 | −324.0 | 5.33 |
| Ep300 SRX7726473 | Natural killer cells Blood | 1069 / 14407 (7.4%) | 2015 / 144070 (1.4%) | −324.0 | −324.0 | 5.31 |
| Nipbl SRX5730168 | B cells Blood | 1302 / 14407 (9.0%) | 2481 / 144070 (1.7%) | −324.0 | −324.0 | 5.25 |
| Ets1 SRX5086093 | Th2 Cells Blood | 1435 / 14407 (10.0%) | 2758 / 144070 (1.9%) | −324.0 | −324.0 | 5.20 |
| Brd4 SRX3113704 | CD4+ T cells Blood | 1354 / 14407 (9.4%) | 2607 / 144070 (1.8%) | −324.0 | −324.0 | 5.19 |
| Rag1 SRX1046554 | Unclassified Unclassified | 1271 / 14407 (8.8%) | 2454 / 144070 (1.7%) | −324.0 | −324.0 | 5.18 |
| Myc SRX5356999 | Naive B cells Blood | 1592 / 14407 (11.1%) | 3078 / 144070 (2.1%) | −324.0 | −324.0 | 5.17 |
| Myc SRX2522382 | Lymphoma cell lines Blood | 1250 / 14407 (8.7%) | 2437 / 144070 (1.7%) | −324.0 | −324.0 | 5.13 |
| Epitope tags SRX3279733 | B cells Blood | 1725 / 14407 (12.0%) | 3380 / 144070 (2.3%) | −324.0 | −324.0 | 5.10 |
| Erg SRX1939438 | Lymphoid-primed multipotent progenitors Blood | 1425 / 14407 (9.9%) | 2801 / 144070 (1.9%) | −324.0 | −324.0 | 5.09 |
| Erg SRX7821113 | Hematopoietic progenitors Blood | 1425 / 14407 (9.9%) | 2801 / 144070 (1.9%) | −324.0 | −324.0 | 5.09 |
| Med12 SRX5086066 | Th2 Cells Blood | 1618 / 14407 (11.2%) | 3190 / 144070 (2.2%) | −324.0 | −324.0 | 5.07 |
| Epitope tags SRX24288473 | Pro-B cells Blood | 1086 / 14407 (7.5%) | 2142 / 144070 (1.5%) | −324.0 | −324.0 | 5.07 |
| Myc SRX353782 | B cells Blood | 1176 / 14407 (8.2%) | 2322 / 144070 (1.6%) | −324.0 | −324.0 | 5.06 |
| Bcl11b SRX1677236 | Thymus Blood | 1088 / 14407 (7.6%) | 2151 / 144070 (1.5%) | −324.0 | −324.0 | 5.06 |
| Bcl11a SRX8030787 | Acute myeloid leukemia Blood | 1147 / 14407 (8.0%) | 2269 / 144070 (1.6%) | −324.0 | −324.0 | 5.06 |
| Men1 SRX415268 | Th2 Cells Blood | 1238 / 14407 (8.6%) | 2463 / 144070 (1.7%) | −324.0 | −324.0 | 5.03 |
| Ep300 SRX15950933 | CD4+ T cells Blood | 1524 / 14407 (10.6%) | 3038 / 144070 (2.1%) | −324.0 | −324.0 | 5.02 |
| Hdac1 SRX1815526 | B cells Blood | 1370 / 14407 (9.5%) | 2735 / 144070 (1.9%) | −324.0 | −324.0 | 5.01 |
| Erg SRX310200 | Mast Cells Blood | 1672 / 14407 (11.6%) | 3339 / 144070 (2.3%) | −324.0 | −324.0 | 5.01 |
| Asxl1 SRX3739259 | Bone Marrow Cells Blood | 1507 / 14407 (10.5%) | 3018 / 144070 (2.1%) | −324.0 | −324.0 | 4.99 |
| Fli1 SRX1056338 | 416B Blood | 1434 / 14407 (10.0%) | 2876 / 144070 (2.0%) | −324.0 | −324.0 | 4.99 |
| Brd4 SRX3729385 | Hematopoietic progenitors Blood | 1390 / 14407 (9.6%) | 2805 / 144070 (1.9%) | −324.0 | −324.0 | 4.96 |
| Brd4 SRX10701687 | Spleen Spleen | 1394 / 14407 (9.7%) | 2816 / 144070 (2.0%) | −324.0 | −324.0 | 4.95 |
| Nipbl SRX8694071 | B cells Blood | 1389 / 14407 (9.6%) | 2821 / 144070 (2.0%) | −324.0 | −324.0 | 4.92 |
| Nipbl SRX320067 | CD4 CD8 double positive cells Blood | 1373 / 14407 (9.5%) | 2796 / 144070 (1.9%) | −324.0 | −324.0 | 4.91 |
| Kmt2a SRX17605412 | Leukemia Blood | 1579 / 14407 (11.0%) | 3247 / 144070 (2.3%) | −324.0 | −324.0 | 4.86 |
| Bcl11b SRX1677234 | Thymus Blood | 2237 / 14407 (15.5%) | 4641 / 144070 (3.2%) | −324.0 | −324.0 | 4.82 |
| Ets1 SRX5086097 | Th2 Cells Blood | 1674 / 14407 (11.6%) | 3474 / 144070 (2.4%) | −324.0 | −324.0 | 4.82 |
| Epitope tags DRX165598 | Unclassified Unclassified | 1309 / 14407 (9.1%) | 2724 / 144070 (1.9%) | −324.0 | −324.0 | 4.81 |
| Rag2 SRX1046543 | Thymocytes Blood | 2160 / 14407 (15.0%) | 4495 / 144070 (3.1%) | −324.0 | −324.0 | 4.81 |
| Nipbl SRX5730166 | B cells Blood | 1740 / 14407 (12.1%) | 3623 / 144070 (2.5%) | −324.0 | −324.0 | 4.80 |
| Epitope tags SRX3219118 | RN2 Blood | 1514 / 14407 (10.5%) | 3168 / 144070 (2.2%) | −324.0 | −324.0 | 4.78 |
| Kat2a SRX1815524 | B cells Blood | 1361 / 14407 (9.4%) | 2852 / 144070 (2.0%) | −324.0 | −324.0 | 4.77 |
| Ep300 SRX7726474 | Natural killer cells Blood | 1289 / 14407 (8.9%) | 2703 / 144070 (1.9%) | −324.0 | −324.0 | 4.77 |
| Epitope tags SRX8244557 | Hematopoietic progenitors Blood | 3439 / 14407 (23.9%) | 7237 / 144070 (5.0%) | −324.0 | −324.0 | 4.75 |
| Kmt2a SRX11002576 | Leukemia Blood | 1208 / 14407 (8.4%) | 2549 / 144070 (1.8%) | −324.0 | −324.0 | 4.74 |
| Brd4 SRX7799914 | CH12 Blood | 1854 / 14407 (12.9%) | 3919 / 144070 (2.7%) | −324.0 | −324.0 | 4.73 |
| Bcor SRX22719795 | Leukemia Blood | 1654 / 14407 (11.5%) | 3501 / 144070 (2.4%) | −324.0 | −324.0 | 4.72 |
| Runx3 SRX8718739 | T progenitor cells Blood | 1739 / 14407 (12.1%) | 3699 / 144070 (2.6%) | −324.0 | −324.0 | 4.70 |
| Ets1 SRX5086095 | Th2 Cells Blood | 1778 / 14407 (12.3%) | 3785 / 144070 (2.6%) | −324.0 | −324.0 | 4.70 |
| Asxl1 SRX3739258 | Bone Marrow Cells Blood | 1704 / 14407 (11.8%) | 3630 / 144070 (2.5%) | −324.0 | −324.0 | 4.69 |
| Myc SRX2522383 | Lymphoma cell lines Blood | 1549 / 14407 (10.8%) | 3302 / 144070 (2.3%) | −324.0 | −324.0 | 4.69 |
| Bach2 SRX2200546 | Pro-B cells Blood | 1860 / 14407 (12.9%) | 3968 / 144070 (2.8%) | −324.0 | −324.0 | 4.69 |
| Cbfb SRX5780109 | CD4+ T cells Blood | 1322 / 14407 (9.2%) | 2833 / 144070 (2.0%) | −324.0 | −324.0 | 4.67 |
| Pou2f1 SRX7368547 | B cells Blood | 1149 / 14407 (8.0%) | 2465 / 144070 (1.7%) | −324.0 | −324.0 | 4.66 |
| Myc SRX5356998 | Naive B cells Blood | 2025 / 14407 (14.1%) | 4350 / 144070 (3.0%) | −324.0 | −324.0 | 4.66 |
| Bcl11b SRX2880136 | CD4+ T cells Blood | 1150 / 14407 (8.0%) | 2476 / 144070 (1.7%) | −324.0 | −324.0 | 4.64 |
| Foxp3 SRX3829344 | Treg Blood | 1179 / 14407 (8.2%) | 2539 / 144070 (1.8%) | −324.0 | −324.0 | 4.64 |
| Ets1 SRX5086094 | Th2 Cells Blood | 2286 / 14407 (15.9%) | 4926 / 144070 (3.4%) | −324.0 | −324.0 | 4.64 |
| Hdac1 SRX7726757 | B cells Blood | 1180 / 14407 (8.2%) | 2548 / 144070 (1.8%) | −324.0 | −324.0 | 4.63 |
| Pou2f1 SRX7368548 | B cells Blood | 1168 / 14407 (8.1%) | 2525 / 144070 (1.8%) | −324.0 | −324.0 | 4.63 |
| Epitope tags SRX24288475 | Pro-B cells Blood | 1411 / 14407 (9.8%) | 3054 / 144070 (2.1%) | −324.0 | −324.0 | 4.62 |
| Myc SRX5357000 | Naive B cells Blood | 1925 / 14407 (13.4%) | 4168 / 144070 (2.9%) | −324.0 | −324.0 | 4.62 |
| Runx3 SRX8718716 | T progenitor cells Blood | 1748 / 14407 (12.1%) | 3789 / 144070 (2.6%) | −324.0 | −324.0 | 4.61 |
| Nipbl SRX8694068 | B cells Blood | 1518 / 14407 (10.5%) | 3297 / 144070 (2.3%) | −324.0 | −324.0 | 4.60 |
| Runx1 DRX165596 | Unclassified Unclassified | 1457 / 14407 (10.1%) | 3168 / 144070 (2.2%) | −324.0 | −324.0 | 4.60 |
| Stat4 SRX7726477 | Natural killer cells Blood | 1831 / 14407 (12.7%) | 3988 / 144070 (2.8%) | −324.0 | −324.0 | 4.59 |
| Kmt2a SRX17605406 | Granulocytic-monocytic progenitors Blood | 2053 / 14407 (14.3%) | 4486 / 144070 (3.1%) | −324.0 | −324.0 | 4.58 |
| Med12 SRX5086068 | Th2 Cells Blood | 1526 / 14407 (10.6%) | 3341 / 144070 (2.3%) | −324.0 | −324.0 | 4.57 |
| Spi1 SRX5507842 | Spleen and lymph nodes Blood | 1439 / 14407 (10.0%) | 3152 / 144070 (2.2%) | −324.0 | −324.0 | 4.57 |
| Nipbl SRX8694069 | B cells Blood | 1638 / 14407 (11.4%) | 3588 / 144070 (2.5%) | −324.0 | −324.0 | 4.57 |
| Runx1 SRX1438366 | EML Blood | 2523 / 14407 (17.5%) | 5531 / 144070 (3.8%) | −324.0 | −324.0 | 4.56 |
| Nipbl SRX13845191 | Scid.adh.2c2 Blood | 1699 / 14407 (11.8%) | 3736 / 144070 (2.6%) | −324.0 | −324.0 | 4.55 |
| Runx1 SRX5358496 | Pro-B cells Blood | 2951 / 14407 (20.5%) | 6517 / 144070 (4.5%) | −324.0 | −324.0 | 4.53 |
| Cbfb SRX5780111 | CD8+ T cells Blood | 1846 / 14407 (12.8%) | 4088 / 144070 (2.8%) | −324.0 | −324.0 | 4.52 |
| Cbfb SRX2389671 | Embryonic liver Embryo | 2024 / 14407 (14.0%) | 4489 / 144070 (3.1%) | −324.0 | −324.0 | 4.51 |
| Nelfb SRX11921266 | Naive T cells Blood | 1192 / 14407 (8.3%) | 2644 / 144070 (1.8%) | −324.0 | −324.0 | 4.51 |
| Ikzf1 SRX692974 | CD4 CD8 double negative cells Blood | 1503 / 14407 (10.4%) | 3334 / 144070 (2.3%) | −324.0 | −324.0 | 4.51 |
| Rad21 SRX7481995 | Pro-B cells Blood | 1694 / 14407 (11.8%) | 3768 / 144070 (2.6%) | −324.0 | −324.0 | 4.50 |
| Kdm2b SRX22719856 | Leukemia Blood | 1869 / 14407 (13.0%) | 4160 / 144070 (2.9%) | −324.0 | −324.0 | 4.49 |
| Spi1 SRX2499699 | Scid.adh.2c2 Blood | 1997 / 14407 (13.9%) | 4460 / 144070 (3.1%) | −324.0 | −324.0 | 4.48 |
| Nipbl SRX8694070 | B cells Blood | 1502 / 14407 (10.4%) | 3358 / 144070 (2.3%) | −324.0 | −324.0 | 4.47 |
| Hdac1 SRX7726758 | B cells Blood | 1606 / 14407 (11.1%) | 3591 / 144070 (2.5%) | −324.0 | −324.0 | 4.47 |
| Runx1 SRX2499764 | Scid.adh.2c2 Blood | 2185 / 14407 (15.2%) | 4916 / 144070 (3.4%) | −324.0 | −324.0 | 4.44 |
| Bcl11b SRX1649982 | Thymus Blood | 2364 / 14407 (16.4%) | 5319 / 144070 (3.7%) | −324.0 | −324.0 | 4.44 |
| Myc SRX353784 | B cells Blood | 1908 / 14407 (13.2%) | 4301 / 144070 (3.0%) | −324.0 | −324.0 | 4.44 |
| Tet2 SRX4232706 | Hematopoietic cells Blood | 1305 / 14407 (9.1%) | 2952 / 144070 (2.0%) | −324.0 | −324.0 | 4.42 |
| Pcgf1 DRX053276 | MEL Blood | 1264 / 14407 (8.8%) | 2864 / 144070 (2.0%) | −324.0 | −324.0 | 4.41 |
| Epitope tags SRX3279734 | B cells Blood | 2684 / 14407 (18.6%) | 6098 / 144070 (4.2%) | −324.0 | −324.0 | 4.40 |
| Ets1 SRX5086099 | Th2 Cells Blood | 2161 / 14407 (15.0%) | 4932 / 144070 (3.4%) | −324.0 | −324.0 | 4.38 |
| Spi1 SRX5026209 | Mast Cells Blood | 1239 / 14407 (8.6%) | 2834 / 144070 (2.0%) | −324.0 | −324.0 | 4.37 |
| N6amt1 SRX8338674 | Tumour organoids Others | 1258 / 14407 (8.7%) | 2883 / 144070 (2.0%) | −324.0 | −324.0 | 4.36 |
| Rad21 SRX7508562 | Pro-B cells Blood | 1305 / 14407 (9.1%) | 2999 / 144070 (2.1%) | −324.0 | −324.0 | 4.35 |
| Brd4 SRX3602867 | iPS cells Pluripotent stem cell | 1314 / 14407 (9.1%) | 3021 / 144070 (2.1%) | −324.0 | −324.0 | 4.35 |
| Nipbl SRX4895107 | CH12 Blood | 1762 / 14407 (12.2%) | 4052 / 144070 (2.8%) | −324.0 | −324.0 | 4.35 |
| Nipbl SRX8694067 | B cells Blood | 1741 / 14407 (12.1%) | 4007 / 144070 (2.8%) | −324.0 | −324.0 | 4.34 |
| Bcl11b SRX2487650 | CD4 CD8 double negative cells Blood | 2723 / 14407 (18.9%) | 6292 / 144070 (4.4%) | −324.0 | −324.0 | 4.33 |
| Rag2 SRX1046552 | B cells Blood | 2460 / 14407 (17.1%) | 5697 / 144070 (4.0%) | −324.0 | −324.0 | 4.32 |
| Runx1 SRX2789670 | Natural Killer T-Cells Blood | 1959 / 14407 (13.6%) | 4540 / 144070 (3.2%) | −324.0 | −324.0 | 4.31 |
| Foxp1 SRX20851843 | CD8+ T cells Blood | 1633 / 14407 (11.3%) | 3786 / 144070 (2.6%) | −324.0 | −324.0 | 4.31 |
| Tcf3 SRX1568865 | Unclassified Unclassified | 1322 / 14407 (9.2%) | 3065 / 144070 (2.1%) | −324.0 | −324.0 | 4.31 |
| Ep300 SRX1815530 | B cells Blood | 1253 / 14407 (8.7%) | 2906 / 144070 (2.0%) | −324.0 | −324.0 | 4.31 |
| Pax5 SRX19312223 | Pro-B cells Blood | 1947 / 14407 (13.5%) | 4526 / 144070 (3.1%) | −324.0 | −324.0 | 4.30 |
| Men1 SRX415267 | Th2 Cells Blood | 1687 / 14407 (11.7%) | 3922 / 144070 (2.7%) | −324.0 | −324.0 | 4.30 |
| Ets1 SRX5086098 | Th2 Cells Blood | 2570 / 14407 (17.8%) | 5987 / 144070 (4.2%) | −324.0 | −324.0 | 4.29 |
| Nipbl SRX5730164 | CH12F3 Blood | 1581 / 14407 (11.0%) | 3684 / 144070 (2.6%) | −324.0 | −324.0 | 4.29 |
| Bcl11b SRX18851332 | Thymocytes Blood | 2362 / 14407 (16.4%) | 5506 / 144070 (3.8%) | −324.0 | −324.0 | 4.29 |
| Nipbl SRX5730169 | B cells Blood | 1687 / 14407 (11.7%) | 3949 / 144070 (2.7%) | −324.0 | −324.0 | 4.27 |
| Nipbl SRX5730171 | B cells Blood | 1733 / 14407 (12.0%) | 4058 / 144070 (2.8%) | −324.0 | −324.0 | 4.27 |
| Bcl11b SRX1677239 | Thymus Blood | 2319 / 14407 (16.1%) | 5434 / 144070 (3.8%) | −324.0 | −324.0 | 4.27 |
| Spi1 SRX2499700 | Scid.adh.2c2 Blood | 1600 / 14407 (11.1%) | 3752 / 144070 (2.6%) | −324.0 | −324.0 | 4.26 |
| Mta2 SRX3660791 | Scid.adh.2c2 Blood | 1233 / 14407 (8.6%) | 2897 / 144070 (2.0%) | −324.0 | −324.0 | 4.26 |
| Nipbl SRX8694063 | T cells Blood | 2220 / 14407 (15.4%) | 5229 / 144070 (3.6%) | −324.0 | −324.0 | 4.25 |
| Runx1 SRX2499765 | Scid.adh.2c2 Blood | 1774 / 14407 (12.3%) | 4186 / 144070 (2.9%) | −324.0 | −324.0 | 4.24 |
| Myc SRX353783 | B cells Blood | 2454 / 14407 (17.0%) | 5802 / 144070 (4.0%) | −324.0 | −324.0 | 4.23 |
| Tmem131 SRX3219121 | RN2 Blood | 1426 / 14407 (9.9%) | 3376 / 144070 (2.3%) | −324.0 | −324.0 | 4.22 |
| Rag2 SRX1046550 | B cells Blood | 2697 / 14407 (18.7%) | 6394 / 144070 (4.4%) | −324.0 | −324.0 | 4.22 |
| Nipbl SRX8694065 | B cells Blood | 2225 / 14407 (15.4%) | 5277 / 144070 (3.7%) | −324.0 | −324.0 | 4.22 |
| Fli1 SRX1939439 | Lymphoid-primed multipotent progenitors Blood | 1912 / 14407 (13.3%) | 4537 / 144070 (3.1%) | −324.0 | −324.0 | 4.21 |
| Fli1 SRX7821115 | Hematopoietic progenitors Blood | 1911 / 14407 (13.3%) | 4536 / 144070 (3.1%) | −324.0 | −324.0 | 4.21 |
| Bcl11b SRX18851331 | Thymocytes Blood | 2360 / 14407 (16.4%) | 5604 / 144070 (3.9%) | −324.0 | −324.0 | 4.21 |
| Med23 SRX20509321 | CH12 Blood | 1512 / 14407 (10.5%) | 3595 / 144070 (2.5%) | −324.0 | −324.0 | 4.21 |
| Bcl11b SRX2487652 | CD4 CD8 double negative cells Blood | 3108 / 14407 (21.6%) | 7401 / 144070 (5.1%) | −324.0 | −324.0 | 4.20 |
| Foxp1 SRX20851844 | CD8+ T cells Blood | 1688 / 14407 (11.7%) | 4023 / 144070 (2.8%) | −324.0 | −324.0 | 4.20 |
| Bcl11b SRX18851333 | Thymocytes Blood | 2444 / 14407 (17.0%) | 5828 / 144070 (4.0%) | −324.0 | −324.0 | 4.19 |
| Epitope tags SRX2486172 | ES cells Pluripotent stem cell | 1390 / 14407 (9.6%) | 3315 / 144070 (2.3%) | −324.0 | −324.0 | 4.19 |
| Bach2 SRX2200545 | Pro-B cells Blood | 2043 / 14407 (14.2%) | 4873 / 144070 (3.4%) | −324.0 | −324.0 | 4.19 |
| Nipbl SRX3753617 | B cells Blood | 2243 / 14407 (15.6%) | 5351 / 144070 (3.7%) | −324.0 | −324.0 | 4.19 |
| Irf4 SRX1131942 | Plasmablasts Blood | 1383 / 14407 (9.6%) | 3305 / 144070 (2.3%) | −324.0 | −324.0 | 4.18 |
| Spi1 SRX1465791 | B cells Blood | 1502 / 14407 (10.4%) | 3594 / 144070 (2.5%) | −324.0 | −324.0 | 4.18 |
| Nipbl SRX5730167 | B cells Blood | 1644 / 14407 (11.4%) | 3935 / 144070 (2.7%) | −324.0 | −324.0 | 4.18 |
| Runx1 SRX2499763 | Scid.adh.2c2 Blood | 1319 / 14407 (9.2%) | 3162 / 144070 (2.2%) | −324.0 | −324.0 | 4.17 |
| Smarcc1 SRX8673307 | Tumor Others | 1276 / 14407 (8.9%) | 3065 / 144070 (2.1%) | −324.0 | −324.0 | 4.16 |
| Runx1 SRX1438367 | EML Blood | 2845 / 14407 (19.7%) | 6847 / 144070 (4.8%) | −324.0 | −324.0 | 4.16 |
| Spi1 SRX091672 | CD4 CD8 double negative cells Blood | 1836 / 14407 (12.7%) | 4421 / 144070 (3.1%) | −324.0 | −324.0 | 4.15 |
| GFP SRX2486160 | C127 Breast | 1588 / 14407 (11.0%) | 3833 / 144070 (2.7%) | −324.0 | −324.0 | 4.14 |
| Pax5 SRX19312225 | Pro-B cells Blood | 1975 / 14407 (13.7%) | 4779 / 144070 (3.3%) | −324.0 | −324.0 | 4.13 |
| Epitope tags SRX3219125 | RN2 Blood | 1505 / 14407 (10.4%) | 3643 / 144070 (2.5%) | −324.0 | −324.0 | 4.13 |
| Fli1 SRX4705104 | MLL-AF9 leukemic cell Blood | 1631 / 14407 (11.3%) | 3960 / 144070 (2.7%) | −324.0 | −324.0 | 4.12 |
| Fli1 SRX310201 | Mast Cells Blood | 2104 / 14407 (14.6%) | 5109 / 144070 (3.5%) | −324.0 | −324.0 | 4.12 |
| Kmt2a SRX22719786 | Leukemia Blood | 1499 / 14407 (10.4%) | 3645 / 144070 (2.5%) | −324.0 | −324.0 | 4.11 |
| Tcf3 SRX2162541 | Pre-B cells Blood | 1975 / 14407 (13.7%) | 4817 / 144070 (3.3%) | −324.0 | −324.0 | 4.10 |
| Rag2 SRX1046542 | Thymocytes Blood | 2816 / 14407 (19.5%) | 6871 / 144070 (4.8%) | −324.0 | −324.0 | 4.10 |
| Runx3 SRX8718717 | T progenitor cells Blood | 2183 / 14407 (15.2%) | 5331 / 144070 (3.7%) | −324.0 | −324.0 | 4.09 |
| Ep300 SRX25655383 | Leukemia Blood | 1667 / 14407 (11.6%) | 4083 / 144070 (2.8%) | −324.0 | −324.0 | 4.08 |
| Spi1 SRX5026213 | Mast Cells Blood | 1411 / 14407 (9.8%) | 3459 / 144070 (2.4%) | −324.0 | −324.0 | 4.08 |
| Spi1 SRX5026212 | Mast Cells Blood | 1472 / 14407 (10.2%) | 3625 / 144070 (2.5%) | −324.0 | −324.0 | 4.06 |
| Kmt2a SRX25655413 | Leukemia Blood | 1486 / 14407 (10.3%) | 3662 / 144070 (2.5%) | −324.0 | −324.0 | 4.06 |
| Bcl11b SRX18851328 | Thymocytes Blood | 2275 / 14407 (15.8%) | 5614 / 144070 (3.9%) | −324.0 | −324.0 | 4.05 |
| Ets1 SRX2499706 | Scid.adh.2c2 Blood | 2712 / 14407 (18.8%) | 6694 / 144070 (4.6%) | −324.0 | −324.0 | 4.05 |
| Tet2 SRX1387481 | MEL Blood | 1384 / 14407 (9.6%) | 3422 / 144070 (2.4%) | −324.0 | −324.0 | 4.04 |
| Cbfb SRX2389673 | Thymocytes Blood | 2240 / 14407 (15.5%) | 5540 / 144070 (3.8%) | −324.0 | −324.0 | 4.04 |
| Nipbl SRX8694066 | B cells Blood | 1706 / 14407 (11.8%) | 4220 / 144070 (2.9%) | −324.0 | −324.0 | 4.04 |
| Wdr5 SRX1815529 | B cells Blood | 1913 / 14407 (13.3%) | 4739 / 144070 (3.3%) | −324.0 | −324.0 | 4.04 |
| Ets1 SRX2499705 | Scid.adh.2c2 Blood | 2755 / 14407 (19.1%) | 6842 / 144070 (4.7%) | −324.0 | −324.0 | 4.03 |
| Kmt2a SRX25655412 | Leukemia Blood | 1305 / 14407 (9.1%) | 3241 / 144070 (2.2%) | −324.0 | −324.0 | 4.03 |
| Bcor SRX22719796 | Leukemia Blood | 2198 / 14407 (15.3%) | 5461 / 144070 (3.8%) | −324.0 | −324.0 | 4.02 |
| Myc SRX353785 | B cells Blood | 2432 / 14407 (16.9%) | 6046 / 144070 (4.2%) | −324.0 | −324.0 | 4.02 |
| Runx3 SRX4677010 | Innate lymphoid cells Blood | 1434 / 14407 (10.0%) | 3567 / 144070 (2.5%) | −324.0 | −324.0 | 4.02 |
| Pax5 SRX7809233 | Pro-B cells Blood | 1425 / 14407 (9.9%) | 3559 / 144070 (2.5%) | −324.0 | −324.0 | 4.00 |
| Ets1 SRX2499704 | Scid.adh.2c2 Blood | 2715 / 14407 (18.8%) | 6788 / 144070 (4.7%) | −324.0 | −324.0 | 4.00 |
| Ikzf1 SRX20340935 | Pre-B cells Blood | 1510 / 14407 (10.5%) | 3784 / 144070 (2.6%) | −324.0 | −324.0 | 3.99 |
| Rag2 SRX1046541 | Thymocytes Blood | 2952 / 14407 (20.5%) | 7400 / 144070 (5.1%) | −324.0 | −324.0 | 3.99 |
| Pax5 SRX7809235 | Pro-B cells Blood | 1543 / 14407 (10.7%) | 3871 / 144070 (2.7%) | −324.0 | −324.0 | 3.99 |
| Spi1 SRX5026211 | Mast Cells Blood | 1639 / 14407 (11.4%) | 4117 / 144070 (2.9%) | −324.0 | −324.0 | 3.98 |
| Brd4 SRX7799919 | CH12 Blood | 2329 / 14407 (16.2%) | 5856 / 144070 (4.1%) | −324.0 | −324.0 | 3.98 |
| Stat5a SRX15950931 | CD4+ T cells Blood | 2108 / 14407 (14.6%) | 5301 / 144070 (3.7%) | −324.0 | −324.0 | 3.98 |
| Kdm1a SRX181863 | Granulocytes Blood | 1644 / 14407 (11.4%) | 4136 / 144070 (2.9%) | −324.0 | −324.0 | 3.97 |
| Biotin SRX10950530 | Pro-B cells Blood | 1610 / 14407 (11.2%) | 4053 / 144070 (2.8%) | −324.0 | −324.0 | 3.97 |
| Runx1 SRX5358492 | Pro-B cells Blood | 3333 / 14407 (23.1%) | 8394 / 144070 (5.8%) | −324.0 | −324.0 | 3.97 |
| Ikzf1 SRX2162555 | Pre-B cells Blood | 1513 / 14407 (10.5%) | 3811 / 144070 (2.6%) | −324.0 | −324.0 | 3.97 |
| Nipbl SRX2755276 | B cells Blood | 2469 / 14407 (17.1%) | 6220 / 144070 (4.3%) | −324.0 | −324.0 | 3.97 |
| Kmt2a SRX17605411 | Leukemia Blood | 2344 / 14407 (16.3%) | 5908 / 144070 (4.1%) | −324.0 | −324.0 | 3.97 |
| Pax5 SRX7809234 | Pro-B cells Blood | 1535 / 14407 (10.7%) | 3870 / 144070 (2.7%) | −324.0 | −324.0 | 3.97 |
| Egr2 SRX270570 | CD4+ T cells Blood | 1567 / 14407 (10.9%) | 3958 / 144070 (2.7%) | −324.0 | −324.0 | 3.96 |
| Hdac1 SRX7726755 | B cells Blood | 1894 / 14407 (13.1%) | 4787 / 144070 (3.3%) | −324.0 | −324.0 | 3.96 |
| Brd4 SRX376583 | MLL-AF9 leukemic cell Blood | 2129 / 14407 (14.8%) | 5389 / 144070 (3.7%) | −324.0 | −324.0 | 3.95 |
| Rad21 SRX23052807 | mESC derived neural cells Pluripotent stem cell | 1352 / 14407 (9.4%) | 3424 / 144070 (2.4%) | −324.0 | −324.0 | 3.95 |
| Pax5 SRX11976741 | Pro-B cells Blood | 2419 / 14407 (16.8%) | 6138 / 144070 (4.3%) | −324.0 | −324.0 | 3.94 |
| Tcf7 SRX24130478 | Thymocytes Blood | 1439 / 14407 (10.0%) | 3658 / 144070 (2.5%) | −324.0 | −324.0 | 3.93 |
| Rbfox2 SRX551545 | MEF Embryonic fibroblast | 1717 / 14407 (11.9%) | 4369 / 144070 (3.0%) | −324.0 | −324.0 | 3.93 |
| Rnf2 SRX9633976 | B cells Blood | 2160 / 14407 (15.0%) | 5504 / 144070 (3.8%) | −324.0 | −324.0 | 3.92 |
| Nipbl SRX4895127 | CH12 Blood | 2573 / 14407 (17.9%) | 6568 / 144070 (4.6%) | −324.0 | −324.0 | 3.92 |
| Nipbl SRX3753614 | B cells Blood | 1676 / 14407 (11.6%) | 4279 / 144070 (3.0%) | −324.0 | −324.0 | 3.92 |
| Runx1 SRX1892671 | 416B Blood | 1569 / 14407 (10.9%) | 4019 / 144070 (2.8%) | −324.0 | −324.0 | 3.90 |
| Kdm2b SRX22719855 | Leukemia Blood | 2374 / 14407 (16.5%) | 6081 / 144070 (4.2%) | −324.0 | −324.0 | 3.90 |
| Runx1 SRX5358488 | Pro-B cells Blood | 1994 / 14407 (13.8%) | 5108 / 144070 (3.5%) | −324.0 | −324.0 | 3.90 |
| Spin1 SRX2704849 | Myoblasts Muscle | 1560 / 14407 (10.8%) | 3999 / 144070 (2.8%) | −324.0 | −324.0 | 3.90 |
| Tcf7 SRX24130479 | Thymocytes Blood | 1460 / 14407 (10.1%) | 3748 / 144070 (2.6%) | −324.0 | −324.0 | 3.90 |
| Spi1 SRX5026214 | Mast Cells Blood | 1621 / 14407 (11.3%) | 4164 / 144070 (2.9%) | −324.0 | −324.0 | 3.89 |
| Fli1 SRX4705106 | MLL-AF9 leukemic cell Blood | 1531 / 14407 (10.6%) | 3936 / 144070 (2.7%) | −324.0 | −324.0 | 3.89 |
| Ikzf3 SRX10166890 | Thymocytes Blood | 2123 / 14407 (14.7%) | 5461 / 144070 (3.8%) | −324.0 | −324.0 | 3.89 |
| Pax5 SRX7809236 | Pro-B cells Blood | 1812 / 14407 (12.6%) | 4686 / 144070 (3.3%) | −324.0 | −324.0 | 3.87 |
| Biotin SRX10950531 | Pro-B cells Blood | 1370 / 14407 (9.5%) | 3545 / 144070 (2.5%) | −324.0 | −324.0 | 3.86 |
| Crebbp SRX25655381 | Leukemia Blood | 2015 / 14407 (14.0%) | 5230 / 144070 (3.6%) | −324.0 | −324.0 | 3.85 |
| Rag2 SRX1046545 | Thymocytes Blood | 3037 / 14407 (21.1%) | 7905 / 144070 (5.5%) | −324.0 | −324.0 | 3.84 |
| Nelfe SRX140395 | MEL Blood | 1569 / 14407 (10.9%) | 4084 / 144070 (2.8%) | −324.0 | −324.0 | 3.84 |
| Runx1 SRX2499762 | Scid.adh.2c2 Blood | 2253 / 14407 (15.6%) | 5870 / 144070 (4.1%) | −324.0 | −324.0 | 3.84 |
| Bcor SRX22719813 | Leukemia Blood | 1798 / 14407 (12.5%) | 4692 / 144070 (3.3%) | −324.0 | −324.0 | 3.83 |
| Hdac1 SRX9519542 | G1E Blood | 2084 / 14407 (14.5%) | 5439 / 144070 (3.8%) | −324.0 | −324.0 | 3.83 |
| Spi1 SRX5026215 | Mast Cells Blood | 1687 / 14407 (11.7%) | 4404 / 144070 (3.1%) | −324.0 | −324.0 | 3.83 |
| Spi1 SRX091673 | CD4 CD8 double negative cells Blood | 1809 / 14407 (12.6%) | 4733 / 144070 (3.3%) | −324.0 | −324.0 | 3.82 |
| Nipbl SRX2755277 | B cells Blood | 2784 / 14407 (19.3%) | 7308 / 144070 (5.1%) | −324.0 | −324.0 | 3.81 |
| Wdr5 SRX1815515 | B cells Blood | 1783 / 14407 (12.4%) | 4682 / 144070 (3.2%) | −324.0 | −324.0 | 3.81 |
| Smarca4 SRX7807053 | Embryonic liver Embryo | 2572 / 14407 (17.9%) | 6761 / 144070 (4.7%) | −324.0 | −324.0 | 3.80 |
| Pax5 SRX19312224 | Pro-B cells Blood | 2513 / 14407 (17.4%) | 6613 / 144070 (4.6%) | −324.0 | −324.0 | 3.80 |
| Yy1 SRX14617702 | CH12 Blood | 1853 / 14407 (12.9%) | 4884 / 144070 (3.4%) | −324.0 | −324.0 | 3.79 |
| Rag2 SRX1046553 | B cells Blood | 3028 / 14407 (21.0%) | 8011 / 144070 (5.6%) | −324.0 | −324.0 | 3.78 |
| Med26 SRX20509320 | CH12 Blood | 2019 / 14407 (14.0%) | 5344 / 144070 (3.7%) | −324.0 | −324.0 | 3.78 |
| Hdac1 SRX1815525 | B cells Blood | 3094 / 14407 (21.5%) | 8203 / 144070 (5.7%) | −324.0 | −324.0 | 3.77 |
| Hdac1 SRX7726756 | B cells Blood | 2042 / 14407 (14.2%) | 5416 / 144070 (3.8%) | −324.0 | −324.0 | 3.77 |
| Bcl11b SRX18851330 | Thymocytes Blood | 2707 / 14407 (18.8%) | 7186 / 144070 (5.0%) | −324.0 | −324.0 | 3.77 |
| Nipbl SRX3753616 | B cells Blood | 2633 / 14407 (18.3%) | 7003 / 144070 (4.9%) | −324.0 | −324.0 | 3.76 |
| Rnf2 SRX105448 | L8057 Blood | 1411 / 14407 (9.8%) | 3759 / 144070 (2.6%) | −324.0 | −324.0 | 3.75 |
| Kmt2a SRX1815528 | B cells Blood | 2896 / 14407 (20.1%) | 7722 / 144070 (5.4%) | −324.0 | −324.0 | 3.75 |
| Bcl11b SRX18851329 | Thymocytes Blood | 2745 / 14407 (19.1%) | 7329 / 144070 (5.1%) | −324.0 | −324.0 | 3.75 |
| Bcl11b SRX3660780 | CD4 CD8 double negative cells Blood | 3408 / 14407 (23.7%) | 9114 / 144070 (6.3%) | −324.0 | −324.0 | 3.74 |
| Kdm4b SRX7794503 | Mesenchymal stem cells Others | 1508 / 14407 (10.5%) | 4033 / 144070 (2.8%) | −324.0 | −324.0 | 3.74 |
| Batf SRX10150718 | CD8+ T cells Blood | 1703 / 14407 (11.8%) | 4556 / 144070 (3.2%) | −324.0 | −324.0 | 3.74 |
| Smarca4 SRX7807050 | Embryonic liver Embryo | 2673 / 14407 (18.6%) | 7160 / 144070 (5.0%) | −324.0 | −324.0 | 3.73 |
| Nipbl SRX8694064 | T cells Blood | 2292 / 14407 (15.9%) | 6143 / 144070 (4.3%) | −324.0 | −324.0 | 3.73 |
| Spi1 SRX2499701 | Scid.adh.2c2 Blood | 1887 / 14407 (13.1%) | 5061 / 144070 (3.5%) | −324.0 | −324.0 | 3.73 |
| Cbfb SRX105447 | L8057 Blood | 1441 / 14407 (10.0%) | 3868 / 144070 (2.7%) | −324.0 | −324.0 | 3.73 |
| Rnf2 SRX9633974 | B cells Blood | 2355 / 14407 (16.3%) | 6337 / 144070 (4.4%) | −324.0 | −324.0 | 3.72 |
| GFP SRX2486159 | C127 Breast | 1887 / 14407 (13.1%) | 5084 / 144070 (3.5%) | −324.0 | −324.0 | 3.71 |
| Tcf3 SRX1568859 | B cells Blood | 1695 / 14407 (11.8%) | 4574 / 144070 (3.2%) | −324.0 | −324.0 | 3.71 |
| Mta2 SRX1205896 | CD4 CD8 double negative cells Blood | 2686 / 14407 (18.6%) | 7255 / 144070 (5.0%) | −324.0 | −324.0 | 3.70 |
| Runx1 SRX3195533 | CD4 CD8 double negative cells Blood | 2479 / 14407 (17.2%) | 6709 / 144070 (4.7%) | −324.0 | −324.0 | 3.70 |
| Gata3 SRX2499768 | Scid.adh.2c2 Blood | 1814 / 14407 (12.6%) | 4916 / 144070 (3.4%) | −324.0 | −324.0 | 3.69 |
| Stat4 SRX7726452 | Natural killer cells Blood | 1597 / 14407 (11.1%) | 4329 / 144070 (3.0%) | −324.0 | −324.0 | 3.69 |
| Mta2 SRX3660756 | CD4 CD8 double negative cells Blood | 1866 / 14407 (13.0%) | 5068 / 144070 (3.5%) | −324.0 | −324.0 | 3.68 |
| Runx1 SRX1901620 | G1E Blood | 1534 / 14407 (10.6%) | 4168 / 144070 (2.9%) | −324.0 | −324.0 | 3.68 |
| Kmt2a SRX1815514 | B cells Blood | 3057 / 14407 (21.2%) | 8311 / 144070 (5.8%) | −324.0 | −324.0 | 3.68 |
| Batf SRX10150717 | CD8+ T cells Blood | 1737 / 14407 (12.1%) | 4723 / 144070 (3.3%) | −324.0 | −324.0 | 3.68 |
| Kdm6b SRX621433 | CD4+ T cells Blood | 1704 / 14407 (11.8%) | 4650 / 144070 (3.2%) | −324.0 | −324.0 | 3.66 |
| Stat4 SRX7726479 | Natural killer cells Blood | 2355 / 14407 (16.3%) | 6442 / 144070 (4.5%) | −324.0 | −324.0 | 3.66 |
| Runx1 SRX5358482 | Pro-B cells Blood | 3431 / 14407 (23.8%) | 9399 / 144070 (6.5%) | −324.0 | −324.0 | 3.65 |
| Mta2 SRX3660755 | CD4 CD8 double negative cells Blood | 2074 / 14407 (14.4%) | 5682 / 144070 (3.9%) | −324.0 | −324.0 | 3.65 |
| Hdac1 SRX9519543 | G1E Blood | 2264 / 14407 (15.7%) | 6206 / 144070 (4.3%) | −324.0 | −324.0 | 3.65 |
| Rnf2 SRX9633975 | B cells Blood | 2551 / 14407 (17.7%) | 6993 / 144070 (4.9%) | −324.0 | −324.0 | 3.65 |
| Tfap4 SRX554972 | CD8+ T cells Blood | 1892 / 14407 (13.1%) | 5187 / 144070 (3.6%) | −324.0 | −324.0 | 3.65 |
| Bcl11b SRX12709528 | CD8+ T cells Blood | 2138 / 14407 (14.8%) | 5863 / 144070 (4.1%) | −324.0 | −324.0 | 3.65 |
| Runx3 SRX8718740 | T progenitor cells Blood | 2869 / 14407 (19.9%) | 7882 / 144070 (5.5%) | −324.0 | −324.0 | 3.64 |
| Nipbl SRX4895128 | CH12 Blood | 2874 / 14407 (19.9%) | 7898 / 144070 (5.5%) | −324.0 | −324.0 | 3.64 |
| Sin3a SRX22262965 | Beta-TC-6 Pancreas | 1522 / 14407 (10.6%) | 4188 / 144070 (2.9%) | −324.0 | −324.0 | 3.63 |
| Runx2 SRX4705109 | MLL-AF9 leukemic cell Blood | 2350 / 14407 (16.3%) | 6485 / 144070 (4.5%) | −324.0 | −324.0 | 3.62 |
| Runx1 SRX1892679 | 416B Blood | 1588 / 14407 (11.0%) | 4387 / 144070 (3.0%) | −324.0 | −324.0 | 3.62 |
| Pax5 SRX19312226 | Pro-B cells Blood | 2456 / 14407 (17.0%) | 6801 / 144070 (4.7%) | −324.0 | −324.0 | 3.61 |
| Kmt2a SRX17605409 | Monocytes Blood | 1593 / 14407 (11.1%) | 4418 / 144070 (3.1%) | −324.0 | −324.0 | 3.61 |
| Spi1 SRX5026216 | Mast Cells Blood | 1927 / 14407 (13.4%) | 5350 / 144070 (3.7%) | −324.0 | −324.0 | 3.60 |
| Fli1 SRX203227 | Megakaryocytes Blood | 1586 / 14407 (11.0%) | 4410 / 144070 (3.1%) | −324.0 | −324.0 | 3.60 |
| Brd4 SRX8379041 | Macrophages Blood | 1902 / 14407 (13.2%) | 5294 / 144070 (3.7%) | −324.0 | −324.0 | 3.59 |
| Brd4 SRX8379040 | Macrophages Blood | 1879 / 14407 (13.0%) | 5233 / 144070 (3.6%) | −324.0 | −324.0 | 3.59 |
| Bcl11b SRX3660779 | CD4 CD8 double negative cells Blood | 3673 / 14407 (25.5%) | 10233 / 144070 (7.1%) | −324.0 | −324.0 | 3.59 |
| Spi1 SRX2499724 | Scid.adh.2c2 Blood | 1688 / 14407 (11.7%) | 4707 / 144070 (3.3%) | −324.0 | −324.0 | 3.59 |
| Stat4 SRX7726478 | Natural killer cells Blood | 2516 / 14407 (17.5%) | 7023 / 144070 (4.9%) | −324.0 | −324.0 | 3.58 |
| Ep300 SRX7726459 | Natural killer cells Blood | 2009 / 14407 (13.9%) | 5615 / 144070 (3.9%) | −324.0 | −324.0 | 3.58 |
| Chd4 SRX1815523 | B cells Blood | 3078 / 14407 (21.4%) | 8608 / 144070 (6.0%) | −324.0 | −324.0 | 3.58 |
| Pax5 SRX5358483 | Pro-B cells Blood | 1638 / 14407 (11.4%) | 4582 / 144070 (3.2%) | −324.0 | −324.0 | 3.57 |
| Mllt3 SRX1902738 | Acute myeloid leukemia Blood | 2107 / 14407 (14.6%) | 5897 / 144070 (4.1%) | −324.0 | −324.0 | 3.57 |
| Hdac2 SRX3660790 | Scid.adh.2c2 Blood | 2431 / 14407 (16.9%) | 6808 / 144070 (4.7%) | −324.0 | −324.0 | 3.57 |
| Pax5 SRX11976740 | Pro-B cells Blood | 2318 / 14407 (16.1%) | 6496 / 144070 (4.5%) | −324.0 | −324.0 | 3.57 |
| Nfya SRX12799801 | Acute myeloid leukemia Blood | 1533 / 14407 (10.6%) | 4328 / 144070 (3.0%) | −324.0 | −324.0 | 3.54 |
| Runx2 SRX4705110 | MLL-AF9 leukemic cell Blood | 2418 / 14407 (16.8%) | 6828 / 144070 (4.7%) | −324.0 | −324.0 | 3.54 |
| Sin3a SRX22262966 | Beta-TC-6 Pancreas | 1573 / 14407 (10.9%) | 4446 / 144070 (3.1%) | −324.0 | −324.0 | 3.54 |
| Hdac2 SRX3660789 | Scid.adh.2c2 Blood | 2722 / 14407 (18.9%) | 7712 / 144070 (5.4%) | −324.0 | −324.0 | 3.53 |
| Rnf2 SRX3660767 | CD4 CD8 double negative cells Blood | 2218 / 14407 (15.4%) | 6291 / 144070 (4.4%) | −324.0 | −324.0 | 3.53 |
| Nipbl SRX4895106 | CH12 Blood | 2817 / 14407 (19.6%) | 8002 / 144070 (5.6%) | −324.0 | −324.0 | 3.52 |
| Nipbl SRX3753615 | B cells Blood | 2608 / 14407 (18.1%) | 7419 / 144070 (5.1%) | −324.0 | −324.0 | 3.52 |
| Kdm2b SRX22719874 | Leukemia Blood | 1568 / 14407 (10.9%) | 4463 / 144070 (3.1%) | −324.0 | −324.0 | 3.51 |
| Ikzf3 SRX10166891 | Thymocytes Blood | 2162 / 14407 (15.0%) | 6158 / 144070 (4.3%) | −324.0 | −324.0 | 3.51 |
| Spi1 SRX2499686 | CD25+ cells Blood | 2598 / 14407 (18.0%) | 7411 / 144070 (5.1%) | −324.0 | −324.0 | 3.51 |
| Ikzf3 SRX10166888 | Thymocytes Blood | 1541 / 14407 (10.7%) | 4406 / 144070 (3.1%) | −324.0 | −324.0 | 3.50 |
| Epitope tags SRX3219123 | RN2 Blood | 2900 / 14407 (20.1%) | 8311 / 144070 (5.8%) | −324.0 | −324.0 | 3.49 |
| Lmo2 SRX7821114 | Hematopoietic progenitors Blood | 2374 / 14407 (16.5%) | 6804 / 144070 (4.7%) | −324.0 | −324.0 | 3.49 |
| Egr2 SRX270569 | CD4+ T cells Blood | 1696 / 14407 (11.8%) | 4861 / 144070 (3.4%) | −324.0 | −324.0 | 3.49 |
| Brd4 SRX884070 | MLL-AF9 leukemic cell Blood | 1602 / 14407 (11.1%) | 4598 / 144070 (3.2%) | −324.0 | −324.0 | 3.48 |
| Cbfb SRX2389674 | Thymocytes Blood | 3457 / 14407 (24.0%) | 9925 / 144070 (6.9%) | −324.0 | −324.0 | 3.48 |
| Lmo2 SRX1939444 | Lymphoid-primed multipotent progenitors Blood | 2370 / 14407 (16.5%) | 6821 / 144070 (4.7%) | −324.0 | −324.0 | 3.47 |
| Kdm2b SRX22719876 | Leukemia Blood | 2208 / 14407 (15.3%) | 6362 / 144070 (4.4%) | −324.0 | −324.0 | 3.47 |
| Tbp SRX22599847 | NIH/3T3 Embryonic fibroblast | 1981 / 14407 (13.8%) | 5718 / 144070 (4.0%) | −324.0 | −324.0 | 3.46 |
| Smarca4 SRX7807052 | Embryonic liver Embryo | 3038 / 14407 (21.1%) | 8772 / 144070 (6.1%) | −324.0 | −324.0 | 3.46 |
| Hdac2 SRX1815527 | B cells Blood | 3139 / 14407 (21.8%) | 9106 / 144070 (6.3%) | −324.0 | −324.0 | 3.45 |
| Med1 SRX1403503 | MLL-AF9 leukemic cell Blood | 1908 / 14407 (13.2%) | 5537 / 144070 (3.8%) | −324.0 | −324.0 | 3.45 |
| Cbfb SRX2389672 | Thymocytes Blood | 3531 / 14407 (24.5%) | 10248 / 144070 (7.1%) | −324.0 | −324.0 | 3.45 |
| Foxp3 SRX2341417 | Treg Blood | 1898 / 14407 (13.2%) | 5511 / 144070 (3.8%) | −324.0 | −324.0 | 3.44 |
| Pax5 SRX10950551 | Pro-B cells Blood | 2099 / 14407 (14.6%) | 6107 / 144070 (4.2%) | −324.0 | −324.0 | 3.44 |
| Spi1 SRX2499689 | CD25+ cells Blood | 1611 / 14407 (11.2%) | 4688 / 144070 (3.3%) | −324.0 | −324.0 | 3.44 |
| Yy1 SRX14617670 | CH12 Blood | 2391 / 14407 (16.6%) | 6963 / 144070 (4.8%) | −324.0 | −324.0 | 3.43 |
| Rbfox2 SRX551553 | MEF Embryonic fibroblast | 1634 / 14407 (11.3%) | 4763 / 144070 (3.3%) | −324.0 | −324.0 | 3.43 |
| Satb1 SRX13440924 | Thymus Blood | 2251 / 14407 (15.6%) | 6564 / 144070 (4.6%) | −324.0 | −324.0 | 3.43 |
| Spi1 SRX5026210 | Mast Cells Blood | 2305 / 14407 (16.0%) | 6722 / 144070 (4.7%) | −324.0 | −324.0 | 3.43 |
| Zfp281 SRX16019903 | Th2 Cells Blood | 1831 / 14407 (12.7%) | 5341 / 144070 (3.7%) | −324.0 | −324.0 | 3.43 |
| Smarca4 SRX7807051 | Embryonic liver Embryo | 3229 / 14407 (22.4%) | 9425 / 144070 (6.5%) | −324.0 | −324.0 | 3.43 |
| Stat5a SRX17605414 | Leukemia Blood | 1831 / 14407 (12.7%) | 5348 / 144070 (3.7%) | −324.0 | −324.0 | 3.42 |
| Spi1 SRX2499688 | CD25+ cells Blood | 1629 / 14407 (11.3%) | 4767 / 144070 (3.3%) | −324.0 | −324.0 | 3.42 |
| Spi1 SRX7692793 | Eosinophils Blood | 1786 / 14407 (12.4%) | 5236 / 144070 (3.6%) | −324.0 | −324.0 | 3.41 |
| Bcl11b SRX663233 | Thymocytes Blood | 1728 / 14407 (12.0%) | 5087 / 144070 (3.5%) | −324.0 | −324.0 | 3.40 |
| Pax5 SRX5358487 | Pro-B cells Blood | 1895 / 14407 (13.2%) | 5581 / 144070 (3.9%) | −324.0 | −324.0 | 3.40 |
| Med1 SRX1403504 | MLL-AF9 leukemic cell Blood | 1586 / 14407 (11.0%) | 4689 / 144070 (3.3%) | −324.0 | −324.0 | 3.38 |
| Yy1 SRX14617672 | CH12 Blood | 2435 / 14407 (16.9%) | 7205 / 144070 (5.0%) | −324.0 | −324.0 | 3.38 |
| Ikzf1 SRX20340936 | Pre-B cells Blood | 1590 / 14407 (11.0%) | 4717 / 144070 (3.3%) | −324.0 | −324.0 | 3.37 |
| Ep300 SRX1565832 | Natural killer cells Blood | 2046 / 14407 (14.2%) | 6084 / 144070 (4.2%) | −324.0 | −324.0 | 3.36 |
| Spi1 SRX1131940 | Plasmablasts Blood | 1968 / 14407 (13.7%) | 5873 / 144070 (4.1%) | −324.0 | −324.0 | 3.35 |
| GFP SRX8244559 | Hematopoietic progenitors Blood | 3603 / 14407 (25.0%) | 10775 / 144070 (7.5%) | −324.0 | −324.0 | 3.34 |
| Foxp3 SRX2341414 | Treg Blood | 1944 / 14407 (13.5%) | 5838 / 144070 (4.1%) | −324.0 | −324.0 | 3.33 |
| Runx1 SRX3195535 | CD4 CD8 double negative cells Blood | 2876 / 14407 (20.0%) | 8641 / 144070 (6.0%) | −324.0 | −324.0 | 3.33 |
| Gata3 SRX2499769 | Scid.adh.2c2 Blood | 2536 / 14407 (17.6%) | 7632 / 144070 (5.3%) | −324.0 | −324.0 | 3.32 |
| Yy1 SRX14617701 | CH12 Blood | 2501 / 14407 (17.4%) | 7536 / 144070 (5.2%) | −324.0 | −324.0 | 3.32 |
| Spi1 SRX2499687 | CD25+ cells Blood | 2606 / 14407 (18.1%) | 7868 / 144070 (5.5%) | −324.0 | −324.0 | 3.31 |
| Kdm2b SRX22719877 | Leukemia Blood | 3017 / 14407 (20.9%) | 9134 / 144070 (6.3%) | −324.0 | −324.0 | 3.30 |
| Smarca4 SRX1815522 | B cells Blood | 3595 / 14407 (25.0%) | 10890 / 144070 (7.6%) | −324.0 | −324.0 | 3.30 |
| Bcl11b SRX663234 | Thymocytes Blood | 1642 / 14407 (11.4%) | 4974 / 144070 (3.5%) | −324.0 | −324.0 | 3.30 |
| Kdm2b SRX22719878 | Leukemia Blood | 1863 / 14407 (12.9%) | 5647 / 144070 (3.9%) | −324.0 | −324.0 | 3.30 |
| Runx1 SRX825830 | mESC derived haematopoietic progenitor Pluripotent stem cell | 2047 / 14407 (14.2%) | 6209 / 144070 (4.3%) | −324.0 | −324.0 | 3.30 |
| Spi1 SRX2499722 | Scid.adh.2c2 Blood | 1888 / 14407 (13.1%) | 5730 / 144070 (4.0%) | −324.0 | −324.0 | 3.29 |
| Kmt2a SRX17605403 | Granulocytic-monocytic progenitors Blood | 3166 / 14407 (22.0%) | 9613 / 144070 (6.7%) | −324.0 | −324.0 | 3.29 |
| Rnf2 SRX3660769 | Bone Marrow Cells Blood | 2075 / 14407 (14.4%) | 6321 / 144070 (4.4%) | −324.0 | −324.0 | 3.28 |
| Yy1 SRX14617700 | CH12 Blood | 2486 / 14407 (17.3%) | 7574 / 144070 (5.3%) | −324.0 | −324.0 | 3.28 |
| Ep300 SRX1565831 | Natural killer cells Blood | 2159 / 14407 (15.0%) | 6596 / 144070 (4.6%) | −324.0 | −324.0 | 3.27 |
| Irf4 SRX2162565 | Pre-B cells Blood | 2483 / 14407 (17.2%) | 7594 / 144070 (5.3%) | −324.0 | −324.0 | 3.27 |
| Kdm6b SRX621429 | CD4+ T cells Blood | 3122 / 14407 (21.7%) | 9551 / 144070 (6.6%) | −324.0 | −324.0 | 3.27 |
| Taf1 SRX19028407 | ES cells Pluripotent stem cell | 1674 / 14407 (11.6%) | 5134 / 144070 (3.6%) | −324.0 | −324.0 | 3.26 |
| Bcl11b SRX2399085 | Thymocytes Blood | 3705 / 14407 (25.7%) | 11372 / 144070 (7.9%) | −324.0 | −324.0 | 3.26 |
| Nfib SRX19694891 | C3H/10T1/2 Embryonic fibroblast | 1914 / 14407 (13.3%) | 5877 / 144070 (4.1%) | −324.0 | −324.0 | 3.26 |
| Brd4 SRX1403500 | MLL-AF9 leukemic cell Blood | 2685 / 14407 (18.6%) | 8251 / 144070 (5.7%) | −324.0 | −324.0 | 3.25 |
| Yy1 SRX14617671 | CH12 Blood | 2536 / 14407 (17.6%) | 7797 / 144070 (5.4%) | −324.0 | −324.0 | 3.25 |
| Ikzf1 SRX205987 | B cells Blood | 2808 / 14407 (19.5%) | 8635 / 144070 (6.0%) | −324.0 | −324.0 | 3.25 |
| Chd4 SRX1815509 | B cells Blood | 2001 / 14407 (13.9%) | 6155 / 144070 (4.3%) | −324.0 | −324.0 | 3.25 |
| Brd4 SRX1114541 | MLL-AF9 leukemic cell Blood | 3610 / 14407 (25.1%) | 11140 / 144070 (7.7%) | −324.0 | −324.0 | 3.24 |
| Spi1 SRX2341952 | LSK cells Blood | 1756 / 14407 (12.2%) | 5423 / 144070 (3.8%) | −324.0 | −324.0 | 3.24 |
| Ikzf3 SRX10166886 | Thymocytes Blood | 2307 / 14407 (16.0%) | 7130 / 144070 (4.9%) | −324.0 | −324.0 | 3.24 |
| Nfib SRX19694889 | C3H/10T1/2 Embryonic fibroblast | 1776 / 14407 (12.3%) | 5490 / 144070 (3.8%) | −324.0 | −324.0 | 3.23 |
| Pax5 SRX10950550 | Pro-B cells Blood | 2767 / 14407 (19.2%) | 8561 / 144070 (5.9%) | −324.0 | −324.0 | 3.23 |
| Spi1 SRX2499721 | Scid.adh.2c2 Blood | 2108 / 14407 (14.6%) | 6529 / 144070 (4.5%) | −324.0 | −324.0 | 3.23 |
| Spi1 SRX2341957 | Hematopoietic Stem Cells Blood | 1891 / 14407 (13.1%) | 5865 / 144070 (4.1%) | −324.0 | −324.0 | 3.22 |
| Rnf2 SRX3660768 | CD4 CD8 double negative cells Blood | 2544 / 14407 (17.7%) | 7891 / 144070 (5.5%) | −324.0 | −324.0 | 3.22 |
| Max SRX9432515 | RAW 264.7 Blood | 2153 / 14407 (14.9%) | 6684 / 144070 (4.6%) | −324.0 | −324.0 | 3.22 |
| Nfib SRX19694893 | C3H/10T1/2 Embryonic fibroblast | 1835 / 14407 (12.7%) | 5712 / 144070 (4.0%) | −324.0 | −324.0 | 3.21 |
| Gfi1 SRX093162 | Bone Marrow Cells Blood | 1948 / 14407 (13.5%) | 6069 / 144070 (4.2%) | −324.0 | −324.0 | 3.21 |
| Nfib SRX19694894 | C3H/10T1/2 Embryonic fibroblast | 1978 / 14407 (13.7%) | 6172 / 144070 (4.3%) | −324.0 | −324.0 | 3.20 |
| Rad21 SRX7481994 | Pro-B cells Blood | 2041 / 14407 (14.2%) | 6386 / 144070 (4.4%) | −324.0 | −324.0 | 3.20 |
| Spi1 SRX2499725 | Scid.adh.2c2 Blood | 2061 / 14407 (14.3%) | 6458 / 144070 (4.5%) | −324.0 | −324.0 | 3.19 |
| Mxi1 SRX140388 | CH12 Blood | 2267 / 14407 (15.7%) | 7119 / 144070 (4.9%) | −324.0 | −324.0 | 3.18 |
| Ikzf1 SRX205986 | B cells Blood | 3286 / 14407 (22.8%) | 10321 / 144070 (7.2%) | −324.0 | −324.0 | 3.18 |
| Nr3c1 SRX4615042 | Lung endothelial cells Cardiovascular | 1945 / 14407 (13.5%) | 6123 / 144070 (4.3%) | −324.0 | −324.0 | 3.18 |
| Smc1a SRX7348141 | Thymocytes Blood | 2153 / 14407 (14.9%) | 6806 / 144070 (4.7%) | −324.0 | −324.0 | 3.16 |
| Spi1 SRX12298594 | B cells Blood | 2031 / 14407 (14.1%) | 6426 / 144070 (4.5%) | −324.0 | −324.0 | 3.16 |
| Ikzf3 SRX10166889 | Thymocytes Blood | 3336 / 14407 (23.2%) | 10573 / 144070 (7.3%) | −324.0 | −324.0 | 3.16 |
| Chd4 SRX3660751 | CD4 CD8 double negative cells Blood | 1998 / 14407 (13.9%) | 6334 / 144070 (4.4%) | −324.0 | −324.0 | 3.15 |
| Smc1a SRX7348145 | CD4 CD8 double positive cells Blood | 2527 / 14407 (17.5%) | 8021 / 144070 (5.6%) | −324.0 | −324.0 | 3.15 |
| Hcfc1 SRX188798 | MEL Blood | 1750 / 14407 (12.1%) | 5559 / 144070 (3.9%) | −324.0 | −324.0 | 3.15 |
| Smc1a SRX7348146 | CD4 CD8 double positive cells Blood | 2650 / 14407 (18.4%) | 8418 / 144070 (5.8%) | −324.0 | −324.0 | 3.15 |
| Med1 SRX1403502 | MLL-AF9 leukemic cell Blood | 2414 / 14407 (16.8%) | 7695 / 144070 (5.3%) | −324.0 | −324.0 | 3.14 |
| Rnf2 SRX3660770 | Bone Marrow Cells Blood | 2220 / 14407 (15.4%) | 7086 / 144070 (4.9%) | −324.0 | −324.0 | 3.13 |
| Spi1 SRX2499682 | CD25+ cells Blood | 2130 / 14407 (14.8%) | 6800 / 144070 (4.7%) | −324.0 | −324.0 | 3.13 |
| Smc1a SRX7348142 | Thymocytes Blood | 2084 / 14407 (14.5%) | 6660 / 144070 (4.6%) | −324.0 | −324.0 | 3.13 |
| Spi1 SRX2499723 | Scid.adh.2c2 Blood | 2198 / 14407 (15.3%) | 7028 / 144070 (4.9%) | −324.0 | −324.0 | 3.13 |
| Smarca4 SRX1815508 | B cells Blood | 3594 / 14407 (24.9%) | 11530 / 144070 (8.0%) | −324.0 | −324.0 | 3.12 |
| Biotin SRX13366572 | Plasmablasts Blood | 1903 / 14407 (13.2%) | 6106 / 144070 (4.2%) | −324.0 | −324.0 | 3.12 |
| Runx1 SRX310206 | Mast Cells Blood | 3260 / 14407 (22.6%) | 10476 / 144070 (7.3%) | −324.0 | −324.0 | 3.11 |
| Smc1a SRX7348143 | CD4 CD8 double positive cells Blood | 2603 / 14407 (18.1%) | 8372 / 144070 (5.8%) | −324.0 | −324.0 | 3.11 |
| Nr3c1 SRX4615041 | Lung endothelial cells Cardiovascular | 1888 / 14407 (13.1%) | 6075 / 144070 (4.2%) | −324.0 | −324.0 | 3.11 |
| Sap130 SRX1568882 | Embryonic heart Embryo | 2020 / 14407 (14.0%) | 6502 / 144070 (4.5%) | −324.0 | −324.0 | 3.11 |
| Kdm4c SRX1755829 | Granulocytic-monocytic progenitors Blood | 1969 / 14407 (13.7%) | 6339 / 144070 (4.4%) | −324.0 | −324.0 | 3.11 |
| Sp1 SRX7799921 | CH12 Blood | 1821 / 14407 (12.6%) | 5876 / 144070 (4.1%) | −324.0 | −324.0 | 3.10 |
| Brd9 SRX5689483 | nTreg Blood | 1770 / 14407 (12.3%) | 5725 / 144070 (4.0%) | −324.0 | −324.0 | 3.09 |
| Phf8 SRX2396659 | Prostate Prostate | 1991 / 14407 (13.8%) | 6449 / 144070 (4.5%) | −324.0 | −324.0 | 3.09 |
| Runx3 SRX7554475 | CD8+ T cells Blood | 2668 / 14407 (18.5%) | 8654 / 144070 (6.0%) | −324.0 | −324.0 | 3.08 |
| Spi1 SRX2499696 | Scid.adh.2c2 Blood | 2275 / 14407 (15.8%) | 7386 / 144070 (5.1%) | −324.0 | −324.0 | 3.08 |
| Smc1a SRX7348144 | CD4 CD8 double positive cells Blood | 2758 / 14407 (19.1%) | 8966 / 144070 (6.2%) | −324.0 | −324.0 | 3.08 |
| Spi1 SRX2499695 | Scid.adh.2c2 Blood | 2657 / 14407 (18.4%) | 8682 / 144070 (6.0%) | −324.0 | −324.0 | 3.06 |
| Eomes SRX4510927 | OT-1 Blood | 2182 / 14407 (15.1%) | 7165 / 144070 (5.0%) | −324.0 | −324.0 | 3.05 |
| Kmt2a SRX17605404 | Granulocytic-monocytic progenitors Blood | 2511 / 14407 (17.4%) | 8263 / 144070 (5.7%) | −324.0 | −324.0 | 3.04 |
| Smarca4 SRX8693962 | Neutrophils Blood | 2417 / 14407 (16.8%) | 8005 / 144070 (5.6%) | −324.0 | −324.0 | 3.02 |
| Hcfc1 SRX188815 | CH12 Blood | 1898 / 14407 (13.2%) | 6290 / 144070 (4.4%) | −324.0 | −324.0 | 3.02 |
| Phf8 SRX2396657 | Prostate Prostate | 2117 / 14407 (14.7%) | 7031 / 144070 (4.9%) | −324.0 | −324.0 | 3.01 |
| Spi1 SRX2341955 | Hematopoietic Stem Cells Blood | 2085 / 14407 (14.5%) | 6929 / 144070 (4.8%) | −324.0 | −324.0 | 3.01 |
| Brd4 SRX1597806 | MLL-AF9 leukemic cell Blood | 2214 / 14407 (15.4%) | 7382 / 144070 (5.1%) | −324.0 | −324.0 | 3.00 |
| Sin3a SRX188801 | CH12 Blood | 2515 / 14407 (17.5%) | 8392 / 144070 (5.8%) | −324.0 | −324.0 | 3.00 |
| Spi1 SRX886478 | B-ALL Blood | 3107 / 14407 (21.6%) | 10368 / 144070 (7.2%) | −324.0 | −324.0 | 3.00 |
| Ep300 SRX183951 | Th1 Cells Blood | 2727 / 14407 (18.9%) | 9137 / 144070 (6.3%) | −324.0 | −324.0 | 2.98 |
| Chd4 SRX3660753 | Bone Marrow Cells Blood | 2416 / 14407 (16.8%) | 8133 / 144070 (5.6%) | −324.0 | −324.0 | 2.97 |
| Gata3 SRX2499767 | Scid.adh.2c2 Blood | 2253 / 14407 (15.6%) | 7587 / 144070 (5.3%) | −324.0 | −324.0 | 2.97 |
| Spi1 SRX1056343 | 416B Blood | 2494 / 14407 (17.3%) | 8443 / 144070 (5.9%) | −324.0 | −324.0 | 2.95 |
| Whsc1l1 SRX1114542 | MLL-AF9 leukemic cell Blood | 3085 / 14407 (21.4%) | 10476 / 144070 (7.3%) | −324.0 | −324.0 | 2.94 |
| Spi1 SRX2499697 | Scid.adh.2c2 Blood | 2709 / 14407 (18.8%) | 9204 / 144070 (6.4%) | −324.0 | −324.0 | 2.94 |
| Ctcf SRX10095030 | Bone Marrow Cells Blood | 3219 / 14407 (22.3%) | 10944 / 144070 (7.6%) | −324.0 | −324.0 | 2.94 |
| Hdac2 SRX1815513 | B cells Blood | 3236 / 14407 (22.5%) | 11002 / 144070 (7.6%) | −324.0 | −324.0 | 2.94 |
| Spi1 SRX2341954 | Hematopoietic Stem Cells Blood | 2240 / 14407 (15.5%) | 7618 / 144070 (5.3%) | −324.0 | −324.0 | 2.94 |
| Bcl11b SRX2399084 | Thymocytes Blood | 4314 / 14407 (29.9%) | 14677 / 144070 (10.2%) | −324.0 | −324.0 | 2.94 |
| Spi1 SRX7368532 | B cells Blood | 2684 / 14407 (18.6%) | 9134 / 144070 (6.3%) | −324.0 | −324.0 | 2.94 |
| Med1 SRX1403505 | MLL-AF9 leukemic cell Blood | 2004 / 14407 (13.9%) | 6825 / 144070 (4.7%) | −324.0 | −324.0 | 2.94 |
| AML1-ETO SRX3491901 | Spleen Spleen | 2110 / 14407 (14.6%) | 7198 / 144070 (5.0%) | −324.0 | −324.0 | 2.93 |
| Runx1 SRX3660776 | CD4 CD8 double negative cells Blood | 3406 / 14407 (23.6%) | 11646 / 144070 (8.1%) | −324.0 | −324.0 | 2.92 |
| Runx1 SRX3195539 | CD4 CD8 double negative cells Blood | 3404 / 14407 (23.6%) | 11645 / 144070 (8.1%) | −324.0 | −324.0 | 2.92 |
| Max SRX140382 | MEL Blood | 1917 / 14407 (13.3%) | 6562 / 144070 (4.6%) | −324.0 | −324.0 | 2.92 |
| Rela SRX6074119 | MEF Embryonic fibroblast | 2603 / 14407 (18.1%) | 8931 / 144070 (6.2%) | −324.0 | −324.0 | 2.91 |
| Kmt2d SRX17605402 | Leukemia Blood | 2608 / 14407 (18.1%) | 8959 / 144070 (6.2%) | −324.0 | −324.0 | 2.91 |
| Spi1 SRX2499683 | CD25+ cells Blood | 2471 / 14407 (17.2%) | 8519 / 144070 (5.9%) | −324.0 | −324.0 | 2.90 |
| Spi1 SRX2188529 | Pro-B cells Blood | 2352 / 14407 (16.3%) | 8113 / 144070 (5.6%) | −324.0 | −324.0 | 2.90 |
| Spi1 SRX2499684 | CD25+ cells Blood | 2468 / 14407 (17.1%) | 8529 / 144070 (5.9%) | −324.0 | −324.0 | 2.89 |
| Mxi1 SRX140391 | MEL Blood | 2428 / 14407 (16.9%) | 8393 / 144070 (5.8%) | −324.0 | −324.0 | 2.89 |
| Hdac2 SRX3660759 | CD4 CD8 double negative cells Blood | 3103 / 14407 (21.5%) | 10772 / 144070 (7.5%) | −324.0 | −324.0 | 2.88 |
| Spi1 SRX8030788 | Acute myeloid leukemia Blood | 2073 / 14407 (14.4%) | 7199 / 144070 (5.0%) | −324.0 | −324.0 | 2.88 |
| Chd4 SRX3660752 | CD4 CD8 double negative cells Blood | 2738 / 14407 (19.0%) | 9512 / 144070 (6.6%) | −324.0 | −324.0 | 2.88 |
| Runx1 SRX3660775 | CD4 CD8 double negative cells Blood | 3430 / 14407 (23.8%) | 11944 / 144070 (8.3%) | −324.0 | −324.0 | 2.87 |
| Runx1 SRX3195537 | CD4 CD8 double negative cells Blood | 3428 / 14407 (23.8%) | 11950 / 144070 (8.3%) | −324.0 | −324.0 | 2.87 |
| Nipbl SRX8693945 | Neutrophils Blood | 2109 / 14407 (14.6%) | 7374 / 144070 (5.1%) | −324.0 | −324.0 | 2.86 |
| Smarca4 SRX8693963 | Neutrophils Blood | 2663 / 14407 (18.5%) | 9319 / 144070 (6.5%) | −324.0 | −324.0 | 2.86 |
| Kdm1a SRX3660771 | CD4 CD8 double negative cells Blood | 2987 / 14407 (20.7%) | 10457 / 144070 (7.3%) | −324.0 | −324.0 | 2.86 |
| Chd4 SRX3660754 | Bone Marrow Cells Blood | 2827 / 14407 (19.6%) | 9899 / 144070 (6.9%) | −324.0 | −324.0 | 2.86 |
| Ascl1 SRX8886261 | Lung tumors Lung | 2442 / 14407 (17.0%) | 8622 / 144070 (6.0%) | −324.0 | −324.0 | 2.83 |
| Nfib SRX19694892 | C3H/10T1/2 Embryonic fibroblast | 2319 / 14407 (16.1%) | 8191 / 144070 (5.7%) | −324.0 | −324.0 | 2.83 |
| AML1-ETO SRX3491900 | Spleen Spleen | 2358 / 14407 (16.4%) | 8342 / 144070 (5.8%) | −324.0 | −324.0 | 2.83 |
| Rad21 SRX2755282 | B cells Blood | 2660 / 14407 (18.5%) | 9432 / 144070 (6.5%) | −324.0 | −324.0 | 2.82 |
| Ascl1 SRX8886262 | Lung tumors Lung | 2083 / 14407 (14.5%) | 7418 / 144070 (5.1%) | −324.0 | −324.0 | 2.81 |
| Epitope tags SRX6370145 | G1E Blood | 2546 / 14407 (17.7%) | 9081 / 144070 (6.3%) | −324.0 | −324.0 | 2.80 |
| Kdm1a SRX3660772 | CD4 CD8 double negative cells Blood | 3092 / 14407 (21.5%) | 11075 / 144070 (7.7%) | −324.0 | −324.0 | 2.79 |
| Hdac2 SRX3660760 | CD4 CD8 double negative cells Blood | 3418 / 14407 (23.7%) | 12269 / 144070 (8.5%) | −324.0 | −324.0 | 2.79 |
| Runx3 SRX7554476 | CD8+ T cells Blood | 2678 / 14407 (18.6%) | 9614 / 144070 (6.7%) | −324.0 | −324.0 | 2.79 |
| Epitope tags SRX6370147 | G1E Blood | 2468 / 14407 (17.1%) | 8892 / 144070 (6.2%) | −324.0 | −324.0 | 2.78 |
| Sin3a SRX188800 | MEL Blood | 2755 / 14407 (19.1%) | 10020 / 144070 (7.0%) | −324.0 | −324.0 | 2.75 |
| Nelfa SRX6714137 | Heart Cardiovascular | 2324 / 14407 (16.1%) | 8495 / 144070 (5.9%) | −324.0 | −324.0 | 2.74 |
| Spi1 SRX8693957 | Neutrophils Blood | 2227 / 14407 (15.5%) | 8148 / 144070 (5.7%) | −324.0 | −324.0 | 2.73 |
| Runx1 SRX3660777 | Bone Marrow Cells Blood | 2733 / 14407 (19.0%) | 10001 / 144070 (6.9%) | −324.0 | −324.0 | 2.73 |
| Phf8 SRX2396658 | Prostate Prostate | 2122 / 14407 (14.7%) | 7767 / 144070 (5.4%) | −324.0 | −324.0 | 2.73 |
| Spi1 SRX7368539 | B cells Blood | 3222 / 14407 (22.4%) | 11814 / 144070 (8.2%) | −324.0 | −324.0 | 2.73 |
| Spi1 SRX2341958 | Granulocytic-monocytic progenitors Blood | 2436 / 14407 (16.9%) | 8954 / 144070 (6.2%) | −324.0 | −324.0 | 2.72 |
| Ep300 SRX8379016 | Macrophages Blood | 2499 / 14407 (17.3%) | 9202 / 144070 (6.4%) | −324.0 | −324.0 | 2.72 |
| Phf8 SRX2396660 | Prostate Prostate | 2198 / 14407 (15.3%) | 8134 / 144070 (5.6%) | −324.0 | −324.0 | 2.70 |
| Ep300 SRX183950 | Th1 Cells Blood | 2445 / 14407 (17.0%) | 9068 / 144070 (6.3%) | −324.0 | −324.0 | 2.70 |
| Runx2 SRX17733008 | ATDC-5 Pluripotent stem cell | 2392 / 14407 (16.6%) | 8887 / 144070 (6.2%) | −324.0 | −324.0 | 2.69 |
| Ep300 SRX8379017 | Macrophages Blood | 2572 / 14407 (17.9%) | 9652 / 144070 (6.7%) | −324.0 | −324.0 | 2.66 |
| Smarcc1 SRX8673311 | Tumor Others | 2959 / 14407 (20.5%) | 11134 / 144070 (7.7%) | −324.0 | −324.0 | 2.66 |
| Spi1 SRX2341959 | Granulocytic-monocytic progenitors Blood | 2525 / 14407 (17.5%) | 9649 / 144070 (6.7%) | −324.0 | −324.0 | 2.62 |
| Runx2 SRX17733007 | ATDC-5 Pluripotent stem cell | 2534 / 14407 (17.6%) | 9709 / 144070 (6.7%) | −324.0 | −324.0 | 2.61 |
| Spi1 SRX310205 | Mast Cells Blood | 3639 / 14407 (25.3%) | 14007 / 144070 (9.7%) | −324.0 | −324.0 | 2.60 |
| Nelfa SRX6714136 | Heart Cardiovascular | 2369 / 14407 (16.4%) | 9150 / 144070 (6.4%) | −324.0 | −324.0 | 2.59 |
| Spi1 SRX2499685 | CD25+ cells Blood | 2919 / 14407 (20.3%) | 11284 / 144070 (7.8%) | −324.0 | −324.0 | 2.59 |
| Irf4 SRX2162564 | Pre-B cells Blood | 2565 / 14407 (17.8%) | 9956 / 144070 (6.9%) | −324.0 | −324.0 | 2.58 |
| Kdm1a SRX3660774 | Bone Marrow Cells Blood | 3181 / 14407 (22.1%) | 12478 / 144070 (8.7%) | −324.0 | −324.0 | 2.55 |
| Ctcf SRX10095027 | Bone Marrow Cells Blood | 3852 / 14407 (26.7%) | 15174 / 144070 (10.5%) | −324.0 | −324.0 | 2.54 |
| Kdm1a SRX3660773 | Bone Marrow Cells Blood | 3004 / 14407 (20.9%) | 11844 / 144070 (8.2%) | −324.0 | −324.0 | 2.54 |
| Ep300 SRX8379020 | Macrophages Blood | 2413 / 14407 (16.7%) | 9568 / 144070 (6.6%) | −324.0 | −324.0 | 2.52 |
| Nr3c1 SRX4615043 | Lung endothelial cells Cardiovascular | 2517 / 14407 (17.5%) | 9993 / 144070 (6.9%) | −324.0 | −324.0 | 2.52 |
| Ep300 SRX183947 | Th1 Cells Blood | 2642 / 14407 (18.3%) | 10557 / 144070 (7.3%) | −324.0 | −324.0 | 2.50 |
| Smc1a SRX20340934 | Pre-B cells Blood | 2442 / 14407 (17.0%) | 9777 / 144070 (6.8%) | −324.0 | −324.0 | 2.50 |
| Epitope tags SRX6370146 | G1E Blood | 2754 / 14407 (19.1%) | 11033 / 144070 (7.7%) | −324.0 | −324.0 | 2.50 |
| Hdac2 SRX3660762 | Bone Marrow Cells Blood | 3245 / 14407 (22.5%) | 13029 / 144070 (9.0%) | −324.0 | −324.0 | 2.49 |
| Jund SRX172347 | Th17 Cells Blood | 2548 / 14407 (17.7%) | 10253 / 144070 (7.1%) | −324.0 | −324.0 | 2.49 |
| Spi1 SRX7821062 | Hematopoietic progenitors Blood | 3324 / 14407 (23.1%) | 13389 / 144070 (9.3%) | −324.0 | −324.0 | 2.48 |
| Rad21 SRX3753624 | B cells Blood | 2820 / 14407 (19.6%) | 11363 / 144070 (7.9%) | −324.0 | −324.0 | 2.48 |
| Spi1 SRX1939448 | Lymphoid-primed multipotent progenitors Blood | 3324 / 14407 (23.1%) | 13398 / 144070 (9.3%) | −324.0 | −324.0 | 2.48 |
| Runx1 SRX3660778 | Bone Marrow Cells Blood | 3214 / 14407 (22.3%) | 12981 / 144070 (9.0%) | −324.0 | −324.0 | 2.48 |
| Hdac2 SRX3660761 | Bone Marrow Cells Blood | 3142 / 14407 (21.8%) | 12771 / 144070 (8.9%) | −324.0 | −324.0 | 2.46 |
| Spi1 SRX2980171 | Myeloid leukemia Blood | 2651 / 14407 (18.4%) | 10800 / 144070 (7.5%) | −324.0 | −324.0 | 2.45 |
| Nr3c1 SRX4615040 | Lung endothelial cells Cardiovascular | 2581 / 14407 (17.9%) | 10614 / 144070 (7.4%) | −324.0 | −324.0 | 2.43 |
| Epitope tags SRX6370142 | G1E Blood | 2899 / 14407 (20.1%) | 12092 / 144070 (8.4%) | −324.0 | −324.0 | 2.40 |
| Epitope tags SRX6370144 | G1E Blood | 2907 / 14407 (20.2%) | 12129 / 144070 (8.4%) | −324.0 | −324.0 | 2.40 |
| Biotin SRX273254 | B cells Blood | 2912 / 14407 (20.2%) | 12370 / 144070 (8.6%) | −324.0 | −324.0 | 2.35 |
| Fli1 SRX884086 | MLL-AF9 leukemic cell Blood | 3105 / 14407 (21.6%) | 13250 / 144070 (9.2%) | −324.0 | −324.0 | 2.34 |
| Kdm1a SRX5056006 | Hematopoietic progenitors Blood | 2740 / 14407 (19.0%) | 11709 / 144070 (8.1%) | −324.0 | −324.0 | 2.34 |
| Spi1 SRX2997921 | Hematopoietic Stem Cells Blood | 2861 / 14407 (19.9%) | 12471 / 144070 (8.7%) | −324.0 | −324.0 | 2.29 |
| Epitope tags SRX6370143 | G1E Blood | 3186 / 14407 (22.1%) | 13922 / 144070 (9.7%) | −324.0 | −324.0 | 2.29 |
| Spi1 SRX2997917 | Hematopoietic Stem Cells Blood | 2870 / 14407 (19.9%) | 12661 / 144070 (8.8%) | −324.0 | −324.0 | 2.27 |
| Spi1 SRX2997919 | Hematopoietic Stem Cells Blood | 3107 / 14407 (21.6%) | 13840 / 144070 (9.6%) | −324.0 | −324.0 | 2.24 |
| Spi1 SRX2997922 | Hematopoietic Stem Cells Blood | 3169 / 14407 (22.0%) | 14122 / 144070 (9.8%) | −324.0 | −324.0 | 2.24 |
Showing first 500 of 11837 rows.